AptaBio Therapeutics Inc. (KOSDAQ:293780)
5,020.00
-100.00 (-1.95%)
Jun 12, 2026, 3:30 PM KST
-35.72% (1Y)
| Market Cap | 141.03B -24.7% |
| Revenue (ttm) | 4.27B +37.5% |
| Net Income | -20.21B |
| EPS | -733.39 |
| Shares Out | 28.09M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 65,454 |
| Open | 5,130.00 |
| Previous Close | 5,120.00 |
| Day's Range | 4,985.00 - 5,310.00 |
| 52-Week Range | 4,640.00 - 11,960.00 |
| Beta | 0.79 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 14, 2026 |